Latest posts
-
Semax and Selank Stack: What Research Reveals About Combining These Soviet-Era Neuropeptides
Semax and Selank Stack: What Research Reveals About Combining These Soviet-Era Neuropeptides Among the neuropeptides that have generated sustained scientific interest over the past four decades, Semax and Selank occupy a distinctive position. Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Both have been the subjects of registered…
-
Weight Loss Peptide Stack Research: Semaglutide, Tirzepatide, and the Next Generation of Metabolic Combinations
The progression from semaglutide (GLP-1R) to tirzepatide (GLP-1R/GIPR) to retatrutide (GLP-1R/GIPR/GCGR) represents one of pharmacology’s most productive recent research trajectories. This article examines the published evidence at each level of receptor combination, what each added target contributed to metabolic outcomes, and the key research questions the field is now investigating.
-
GH Secretagogue Stack Research: CJC-1295 and Ipamorelin as a Dual-Mechanism Protocol
The CJC-1295 and ipamorelin combination is one of the most referenced dual-mechanism GH secretagogue protocols in research literature. This article examines the published pharmacological basis for GHRH and GHRP pathway synergy, why this specific pairing is commonly studied, and what the peer-reviewed literature does and does not establish about the combination.
-
BPC-157 and TB-500 Stack: What the Research Says About Combining These Two Recovery Peptides
The combination of BPC-157 and TB-500 is one of the most discussed peptide stacks in tissue repair research. This article examines the mechanistic rationale based on each compound’s published individual biology — BPC-157’s angiogenic and growth factor effects alongside TB-500’s cell migration mechanisms — and clearly distinguishes what the peer-reviewed literature does and does not…
